Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature

by Luba Nalysnyk, Javier Cid-Ruzafa, Philip Rotella, Dirk Esser
Published 2012-12-01

A health state utility valuation study to assess the impact of treatment mode of administration in Gaucher disease

by Monica Hadi, Paul Swinburn, Luba Nalysnyk, Alaa Hamed, Atul Mehta
Published 2018-09-01

A new framework for evaluating the health impacts of treatment for Gaucher disease type 1

by Michael L. Ganz, Sean Stern, Alex Ward, Luba Nalysnyk, Martin Selzer, Alaa Hamed, Neal Weinreb
Published 2017-02-01